UNIGE document Scientific Article
previous document  unige:151663  next document
add to browser collection
Title

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Authors
Smolen, Josef S
Landewé, Robert B M
Bijlsma, Johannes W J
Burmester, Gerd R
Dougados, Maxime
Kerschbaumer, Andreas
McInnes, Iain B
Sepriano, Alexandre
show hidden authors show all authors [1 - 47]
Published in Annals of the Rheumatic Diseases. 2020, vol. 79, no. 6, p. 685-699
Abstract To provide an update of the European League Against Rheumatism (EULAR) rheumatoid arthritis (RA) management recommendations to account for the most recent developments in the field.
Keywords Antirheumatic Agents/economics/therapeutic useArthritisRheumatoid/drug therapyBiological Products/economics/therapeutic useConsensusDrug TherapyCombinationEuropeHumansJanus Kinase Inhibitors/therapeutic useSocietiesMedicalSynthetic Drugs/economics/therapeutic useSystematic Reviews as TopicTumor Necrosis Factor-alpha/antagonists & inhibitors
Identifiers
PMID: 31969328
Full text
Article (Published version) (1.4 MB) - public document Free access
Structures
Research group Recherche clinique en rhumatismes inflammatoires (1010)
Citation
(ISO format)
SMOLEN, Josef S et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. In: Annals of the Rheumatic Diseases, 2020, vol. 79, n° 6, p. 685-699. doi: 10.1136/annrheumdis-2019-216655 https://archive-ouverte.unige.ch/unige:151663

17 hits

7 downloads

Update

Deposited on : 2021-05-17

Export document
Format :
Citation style :